Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Personalised medicine

Marshall A (1997). Laying the foundations for personalised medicines. Nature Biotechnology,... [Pg.273]

The patient individualisation should include activities for identification, resolving and preventing drug-related problems as described by pharmaceutical care and medication review and possible with the additional personalised medicine support... [Pg.125]

EBM (3), inappropriate drugs (4), correct dose (2), food interactions (8), personalised medicine (10), renal elimination (2), common conditions (5), neuro-psychiatric disorders (6)... [Pg.131]

Gurwitz, D., A. Wiezman, and M. Rehavi. 2003. Teaching pharmacogenomics to prepare future physicians and researchers for personalised medicine. Trends Pharmacol Sci 24 122. [Pg.211]

Identifying Susceptibility Loci Towards Personalised Medicine... [Pg.12]

Kalow W. Pharmacogenetics and personalised medicine. Fundam Clin Pharmacol 2002 16 337-342. [Pg.44]

Guiducd C et al. ISyPeM Intelligent Integrated Systems for Personalised Medicine, http // www.nano-terach/projects/405.php... [Pg.250]

Harrell FE Jr., Lee KL, Mark DB (1996). Multivariable prognostic models issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15 361-387 Hart RG (2007). Antithrombotic therapy to prevent stroke in patients with atrial fibrillation. In Treating Individuals From Randomized Trials to Personalised Medicine, Rothwell PM (ed.) pp. 265-278. London Elsevier... [Pg.192]

Diks SH, Peppelenbosch MP (2004) Single cell proteomics for personalised medicine. Trends Mol Med 10 574-577. [Pg.738]

Personalised Medicines Hopes and Realities. A report by The Royal Society. London The Royal Society, 2005. [Pg.509]

The potential regulatory challenges of personalised medicine. Available at www.mhra.gov.uk. [Pg.509]

Through the combination of personal medical history, a patient s family history, and diagnostic testing, medicine has always sought to personalise medicine. Personalised medicine is in no way a new idea however. For literally... [Pg.429]

Currently, the greatest progress is in personalising oncology, where personalised medicine may improve treatment of these still-high mortality diseases by identifying specific patient subsets to which receptor-specific therapy can be... [Pg.430]

The role of genetics is attracting considerable attention. Numerous examples of genetic predisposition to ADRs exist in the literature. The recent sequencing of the human genome has focused attention on the more widespread use of genotype data to reduce the potential of an adverse drug response and permit personalised medicines. [Pg.236]

The Royal Society Report, Personalised medicines Hopes and realities, September 21, 2005. Available at www.royalsoc.ac.uk/displaypagedoc.asp id=23244. [Pg.111]

R.F. Pereira, H.A. Almeida, and P.J. B rtolo, "Biofabrication of hydrogel constructs," in J. Coelho, ed.. Drug Delivery Systems Advanced Technologies Potentially Applicable in Personalised Treatment, Vol. 4 of Ad-vances in Predictive, Preventive and Personalised Medicine, pp. 225-254. Springer Netherlands, 2013. [Pg.286]

See other pages where Personalised medicine is mentioned: [Pg.141]    [Pg.119]    [Pg.125]    [Pg.125]    [Pg.154]    [Pg.624]    [Pg.627]    [Pg.15]    [Pg.211]    [Pg.192]    [Pg.107]    [Pg.493]    [Pg.494]    [Pg.496]    [Pg.1550]    [Pg.310]    [Pg.430]    [Pg.431]    [Pg.919]    [Pg.919]    [Pg.99]    [Pg.126]    [Pg.848]    [Pg.32]    [Pg.44]    [Pg.58]    [Pg.101]    [Pg.98]    [Pg.181]   
See also in sourсe #XX -- [ Pg.119 , Pg.125 , Pg.131 ]



SEARCH



© 2024 chempedia.info